Vitamin D Supplementation for Extremely Preterm Infants

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Vitamin D Deficiency, Preterm Infants, Bronchopulmonary Dysplasia

In brief

The study hypothesis states that giving early enteral Vitamin D supplementation to preterm infants will decrease respiratory morbidity in extremely preterm infants.

Key facts

Study ID

NCT01600430

Run by

University of Alabama at Birmingham

People needed

100

Starts

2012-06-01

Expected to finish

2016-12-01

Last updated by the study team

2017-02-10

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Infants admitted to the Regional Newborn ICU of the University of Alabama with gestational age between 23-27 completed weeks

You may not qualify if…

• Major congenital/chromosomal anomalies
• Moribund infant with low likelihood of survival, in opinion of the clinical team

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.